Scholar Rock Holding Corp (SRRK)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Jay T. Backstrom
Employees:
140
620 MEMORIAL DRIVE, 2ND FLOOR, CAMBRIDGE, MA 02139
857-259-3860

Scholar Rock Holding Corporation focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin, and SRK-181, which is in Phase 1 clinical trials. It is also developing a pipeline of novel product candidates with potential to transform the lives of patients.

Data derived from most recent annual or quarterly report
Market Cap 874.413 Million Shares Outstanding56.232 Million Avg 30-day Volume 748.194 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.55
Price to Revenue0.0 Debt to Equity0.298 EBITDA-166.473 Million
Price to Book Value3.4134 Operating Margin0.0 Enterprise Value403.63 Million
Current Ratio8.547 EPS Growth0.308 Quick Ratio8.179
1 Yr BETA 0.698 52-week High/Low 15.75 / 5.56 Profit Margin0.0
Operating Cash Flow Growth-0.3978 Free Cash Flow to Firm (FCFF) TTM -113.391 Million Free Cash Flow to Equity (FCFE) TTM-113.8 Million
Altman Z-Score-0.5731
View SEC Filings from SRRK instead.

View recent insider trading info

Scholar Rock Holding Corp YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding SRRK (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SRRK

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-09-20 by QATANANI MO
  • 4: filed on 2023-08-18 by PARLAVECCHIO CARYN
  • 4: filed on 2023-06-22 by REED JOSHUA
  • 4: filed on 2023-06-22 by FLIER JEFFREY S.
  • 3: filed on 2023-06-22 by SACCO TRACEY
  • 3: filed on 2023-06-22 by QATANANI MO
  • 4: filed on 2023-06-22 by PARLAVECCHIO CARYN
  • 4: filed on 2023-06-22 by HO JUNLIN
  • 4: filed on 2023-04-10 by BRUDNICK RICHARD
  • 3: filed on 2023-04-10 by BRUDNICK RICHARD

    • Events (8k)

  • 8-K: filed on 2023-11-07:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-10-12:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-10-11:
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-30:
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-22:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-05-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-10:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-13:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2023-03-07:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

  • 144: filed on 2023-11-02:

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    6.6 Million total shares from 4 transactions

    Open Market Sells (S)

    35 Thousand total shares from 1 transactions

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    NASHAT AMIR

    • Director
    		 3,268,505 2023-11-20 2

    MYLES EDWARD H COO & CFO

    • Officer
    		 168,784 2023-11-02 4

    AKKARAJU SRINIVAS

    • Director
    • 10% Owner
    		 6,788,609 2023-10-16 2

    SAMSARA BIOCAPITAL GP, LLC

    SAMSARA BIOCAPITAL, L.P.

    • 10% Owner
    		 6,788,609 2023-10-16 1

    INVUS PUBLIC EQUITIES, L.P.

    ARTAL INTERNATIONAL S.C.A.

    ARTAL INTERNATIONAL MANAGEMENT S.A.

    ARTAL GROUP S.A.

    WESTEND S.A.

    STICHTING ADMINISTRATIEKANTOOR WESTEND

    WITTOUCK AMAURY

    INVUS PUBLIC EQUITIES ADVISORS, LLC

    • 10% Owner
    		 11,259,438 2023-10-12 4

    QATANANI MO SVP AND HEAD OF RESEARCH

    • Officer
    		 97,043 2023-09-18 2

    PARLAVECCHIO CARYN CHRO

    • Officer
    		 117,199 2023-08-16 4

    GILMAN MICHAEL

    • Director
    		 0 2023-06-21 1

    HALLAL DAVID

    • Director
    		 0 2023-06-21 1

    VAISHNAW AKSHAY

    • Director
    		 0 2023-06-21 1

    BUROW KRISTINA

    • Director
    		 0 2023-06-21 1

    FLIER JEFFREY S.

    • Director
    		 0 2023-06-21 1

    REED JOSHUA

    • Director
    		 0 2023-06-21 1

    HO JUNLIN GENERAL COUNSEL

    • Officer
    		 158,591 2023-06-21 3

    SACCO TRACEY CHIEF COMMERCIAL OFFICER

    • Officer
    		 0 2023-06-21 1

    BRUDNICK RICHARD

    • Director
    		 0 2023-04-06 2

    BACKSTROM JAY T. CHIEF EXECUTIVE OFFICER

    • Officer
    		 150,000 2023-02-13 1

    MARANTZ JING L. CHIEF MEDICAL OFFICER

    • Officer
    		 250,000 2022-11-14 0

    MAHANTHAPPA NAGESH K. INTERIM CEO AND PRESIDENT

    • Officer
    		 530,491 2022-06-16 0

    CARVEN GREGORY JOHN CHIEF SCIENTIFIC OFFICER

    • Officer
    		 173,708 2022-06-16 0

    CHYUNG YUNG H. CHIEF MEDICAL OFFICER

    • Officer
    		 295,996 2022-02-14 0

    KINGSLEY STUART A PRESIDENT AND CEO

    • Officer
    • Director
    		 42,000 2021-02-01 0

    BUCKLER ALAN J. CHIEF SCIENTIFIC OFFICER

    • Officer
    		 0 2020-02-06 0

    MOORE ERIN SVP, FINANCE

    • Officer
    		 0 2020-02-06 0

    SPRINGER TIMOTHY A

    • 10% Owner
    		 No longer subject to file 2019-12-10 0

    CHICKO RHONDA M. CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2019-01-31 0

    MYLES EDWARD H

    MYLES EDWARD H

    • Director
    		 0 2018-11-19 4

    ARTAL INTERNATIONAL S.C.A.

    INVUS PUBLIC EQUITIES, L.P.

    INVUS PUBLIC EQUITIES ADVISORS, LLC

    ARTAL INTERNATIONAL MANAGEMENT S.A.

    ARTAL GROUP S.A.

    WESTEND S.A.

    STICHTING ADMINISTRATIEKANTOOR WESTEND

    MINNE PASCAL

    • 10% Owner
    		 No longer subject to file 2018-05-29 0

    ARCH VENTURE FUND VIII, L.P.

    ARCH VENTURE PARTNERS VIII, LLC

    CRANDELL KEITH

    BYBEE CLINTON

    NELSEN ROBERT

    ARCH VENTURE PARTNERS VIII, L.P.

    • 10% Owner
    		 2,637,617 2018-05-29 0

    EZICKSON ELAN COO & HEAD OF CORP.DEVELOPMENT

    • Officer
    		 0 2018-05-29 0

    POLARIS VENTURE MANAGEMENT CO. VI, L.L.C.

    POLARIS VENTURE PARTNERS VI, L.P.

    POLARIS VENTURE PARTNERS FOUNDERS' FUND VI, L.P.

    • 10% Owner
    		 2,832,706 2018-05-29 0

    ARTAL INTERNATIONAL S.C.A.

    ARTAL INTERNATIONAL MANAGEMENT S.A.

    ARTAL GROUP S.A.

    WESTEND S.A.

    STICHTING ADMINISTRATIEKANTOOR WESTEND

    MINNE PASCAL

    • 10% Owner
    		 0 2018-05-23 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    NASHAT AMIR - Director

    		2023-11-22 16:30:32 -0500 2023-11-20 J 37 a 20,574 direct 1.9591 14.5656 14.5656 6 -0.937 3

    NASHAT AMIR - Director see footnote

    		2023-11-22 16:30:32 -0500 2023-11-20 J 276 a 276 indirect 1.9591 14.5656 14.5656 6 -0.937 3

    NASHAT AMIR - Director see footnote

    		2023-11-22 16:30:32 -0500 2023-11-20 J 276 d 0 indirect 1.9591 14.5656 14.5656 6 -0.937 3

    NASHAT AMIR - Director see footnote

    		2023-11-22 16:30:32 -0500 2023-11-20 J 322 a 504 indirect 1.9591 14.5656 14.5656 6 -0.937 3

    NASHAT AMIR - Director

    		2023-11-22 16:30:32 -0500 2023-11-20 J 13,096 a 20,537 direct 1.9591 14.5656 14.5656 6 -0.937 3

    NASHAT AMIR - Director see footnote

    		2023-11-22 16:30:32 -0500 2023-11-20 J 27,606 d 179,291 indirect 1.9591 14.5656 14.5656 6 -0.937 3

    NASHAT AMIR - Director see footnote

    		2023-11-22 16:30:32 -0500 2023-11-20 J 98,261 a 98,261 indirect 1.9591 14.5656 14.5656 6 -0.937 3

    NASHAT AMIR - Director see footnote

    		2023-11-22 16:30:32 -0500 2023-11-20 J 98,261 d 0 indirect 1.9591 14.5656 14.5656 6 -0.937 3

    NASHAT AMIR - Director see footnote

    		2023-11-22 16:30:32 -0500 2023-11-20 J 472,394 d 3,068,136 indirect 1.9591 14.5656 14.5656 6 -0.937 3

    MYLES EDWARD H - Officer COO & CFO

    		2023-11-03 18:11:01 -0400 2023-11-02 S 35,007 $12.51 d 168,784 direct yes 1.479 -18.8168 1.479 2 -18.8168 6

    SAMSARA BIOCAPITAL GP, LLC - > 10% Owner by samsara biocapital, l.p.

    SAMSARA BIOCAPITAL, L.P. - > 10% Owner by samsara biocapital, l.p.

    		2023-10-18 17:44:33 -0400 2023-10-16 P 2,189,781 $6.85 a 6,788,609 indirect 1.8667 41.4667 79.3333 79.3333 31 0.0 1

    AKKARAJU SRINIVAS - Director - > 10% Owner by samsara biocapital, l.p.

    		2023-10-18 17:46:02 -0400 2023-10-16 P 2,189,781 $6.85 a 6,788,609 indirect 1.8667 41.4667 79.3333 79.3333 31 0.0 1

    INVUS PUBLIC EQUITIES, L.P. - > 10% Owner

    ARTAL INTERNATIONAL S.C.A. - > 10% Owner

    ARTAL INTERNATIONAL MANAGEMENT S.A. - > 10% Owner

    ARTAL GROUP S.A. - > 10% Owner

    WESTEND S.A. - > 10% Owner

    STICHTING ADMINISTRATIEKANTOOR WESTEND - > 10% Owner

    WITTOUCK AMAURY - > 10% Owner

    INVUS PUBLIC EQUITIES ADVISORS, LLC - > 10% Owner

    		2023-10-16 17:46:56 -0400 2023-10-12 P 10,150 $8.55 a 11,259,438 direct -13.5632 -11.954 38.9655 44.1379 13 -13.7931 3

    INVUS PUBLIC EQUITIES, L.P. - > 10% Owner

    ARTAL INTERNATIONAL S.C.A. - > 10% Owner

    ARTAL INTERNATIONAL MANAGEMENT S.A. - > 10% Owner

    ARTAL GROUP S.A. - > 10% Owner

    WESTEND S.A. - > 10% Owner

    STICHTING ADMINISTRATIEKANTOOR WESTEND - > 10% Owner

    WITTOUCK AMAURY - > 10% Owner

    INVUS PUBLIC EQUITIES ADVISORS, LLC - > 10% Owner

    		2023-10-16 17:46:56 -0400 2023-10-12 P 2,189,781 $6.85 a 11,249,288 direct -13.5632 -11.954 38.9655 44.1379 13 -13.7931 3

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    SCHOLAR ROCK HOLDING CORP SRRK 2023-12-05 22:15:04 UTC 4.9018 0.4182 500000
    SCHOLAR ROCK HOLDING CORP SRRK 2023-12-05 21:45:04 UTC 4.9018 0.4182 500000
    SCHOLAR ROCK HOLDING CORP SRRK 2023-12-05 21:15:04 UTC 4.9018 0.4182 500000
    SCHOLAR ROCK HOLDING CORP SRRK 2023-12-05 20:45:04 UTC 4.9018 0.4182 500000
    SCHOLAR ROCK HOLDING CORP SRRK 2023-12-05 20:15:04 UTC 4.9018 0.4182 500000
    SCHOLAR ROCK HOLDING CORP SRRK 2023-12-05 19:45:04 UTC 4.9018 0.4182 500000
    SCHOLAR ROCK HOLDING CORP SRRK 2023-12-05 19:15:04 UTC 4.9018 0.4182 500000
    SCHOLAR ROCK HOLDING CORP SRRK 2023-12-05 18:45:04 UTC 4.9018 0.4182 500000
    SCHOLAR ROCK HOLDING CORP SRRK 2023-12-05 18:15:03 UTC 4.9018 0.4182 500000
    SCHOLAR ROCK HOLDING CORP SRRK 2023-12-05 17:45:04 UTC 4.9018 0.4182 500000
    SCHOLAR ROCK HOLDING CORP SRRK 2023-12-05 17:15:04 UTC 4.9018 0.4182 500000
    SCHOLAR ROCK HOLDING CORP SRRK 2023-12-05 16:45:04 UTC 4.9018 0.4182 500000
    SCHOLAR ROCK HOLDING CORP SRRK 2023-12-05 16:15:04 UTC 4.9018 0.4182 500000
    SCHOLAR ROCK HOLDING CORP SRRK 2023-12-05 15:45:04 UTC 4.9018 0.4182 500000
    SCHOLAR ROCK HOLDING CORP SRRK 2023-12-05 15:15:05 UTC 4.9018 0.4182 500000
    SCHOLAR ROCK HOLDING CORP SRRK 2023-12-05 14:45:03 UTC 4.6281 0.6919 500000
    SCHOLAR ROCK HOLDING CORP SRRK 2023-12-05 14:15:04 UTC 4.6281 0.6919 500000
    SCHOLAR ROCK HOLDING CORP SRRK 2023-12-05 13:45:04 UTC 4.6281 0.6919 500000
    SCHOLAR ROCK HOLDING CORP SRRK 2023-12-05 13:15:04 UTC 4.6281 0.6919 500000
    SCHOLAR ROCK HOLDING CORP SRRK 2023-12-05 12:45:05 UTC 4.6281 0.6919 500000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund SRRK -1089.0 shares, $-7731.9 2023-07-31 N-PORT
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund SRRK -3100.0 shares, $-22010.0 2023-09-30 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments